PARNATE Drug Patent Profile
Which patents cover Parnate, and what generic alternatives are available?
Parnate is a drug marketed by Advanz Pharma and is included in one NDA.
The generic ingredient in PARNATE is tranylcypromine sulfate. There is one drug master file entry for this compound. Six suppliers are listed for this compound. Additional details are available on the tranylcypromine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Parnate
A generic version of PARNATE was approved as tranylcypromine sulfate by STRIDES PHARMA INTL on June 29th, 2006.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PARNATE?
- What are the global sales for PARNATE?
- What is Average Wholesale Price for PARNATE?
Summary for PARNATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 72 |
| Clinical Trials: | 6 |
| Patent Applications: | 4,051 |
| Drug Prices: | Drug price information for PARNATE |
| What excipients (inactive ingredients) are in PARNATE? | PARNATE excipients list |
| DailyMed Link: | PARNATE at DailyMed |
Recent Clinical Trials for PARNATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Sheppard Pratt Health System | N/A |
| Central Michigan University | N/A |
| National Institute of Mental Health (NIMH) | Phase 4 |
Pharmacology for PARNATE
| Drug Class | Monoamine Oxidase Inhibitor |
| Mechanism of Action | Monoamine Oxidase Inhibitors |
US Patents and Regulatory Information for PARNATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Advanz Pharma | PARNATE | tranylcypromine sulfate | TABLET;ORAL | 012342-003 | Aug 16, 1985 | AB | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
